Cited by 7Autism Spectrum Disorder ResearchFamily and Disability Support ResearchChild Nutrition and Feeding Issues

Treating Children with ASD: The Perspective of Caregivers

Open access
Breik, Noor, Kuo, I fan, Bugden, Shawn, Moffat, Michael, Alessi-Severini, Silvia·2018·Journal of Pharmacy & Pharmaceutical Sciences

Abstract

Purpose: Treatment of Autism Spectrum Disorders (ASD) is challenging. Parents/caregivers’ perspective on the effectiveness of therapies and services available to their children is important but neglected in the literature on ASD. This study investigated such perspective through questionnaire-guided interviews with a group of parents in the province of Manitoba (Canada). A secondary objective of the study was to explore how health care professionals and specifically pharmacists can assist in providing better care to children with ASD. Methods: Informed consent was obtained from all participants. Data on diagnoses and prescribed medications were collected from medical charts. Parents/caregivers completed questionnaires during interviews scheduled at their convenience. Specific questions were asked to gather caregivers/parents’ perspectives on the effectiveness of medications and non-pharmacological interventions in controlling symptoms experienced by their children. Information on access to education and health services was also assessed. Common themes were identified using thematic analysis. Results: All children attended school, 88% were males, 50% experienced eating/sleeping difficulties; 69% reported Attention Deficit Hyperactivity Disorder comorbidity. Risperidone was reported to be effective in controlling aggressive behaviours. Methylphenidate and aripiprazole were often discontinued. Melatonin and occupational therapy services were said to be very useful. Access to behavioural therapy was often limited. Parents were concerned about lack of trained professionals in schools, limited understanding of their children’s needs, and uncertainty for the future. Conclusions: Better education and awareness are necessary to help ASD children and their families. Pharmacists should explore opportunities to provide better services. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18433/jpps29829

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 23 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA): Canadian ADHD Practice Guidelines, Third Edition, Toronto ON; CADDRA, 2011. http://www.caddra.ca Accessed on July 31, 2017
  2. National Research Council, Committee on Educational Interventions for Children with Autism. Educating Children with Autism, Lord C, McGee JP (Eds), (2001) National Academy Press, Washington, DC.

Cited by

Sorted by citations

Authors
Breik, N., Kuo, I. F., Bugden, S., Moffat, M., & Alessi-Severini, S.
Affiliations
University of Manitoba (CA)
Venue
Journal of Pharmacy & Pharmaceutical Sciences
Published
2018-05-07
Volume
21
Issue
1s
Pages
74s-87s
ISSN
1482-1826 (ISSN-L)
OpenAlex
W2799473455
Cited by
7
References
23
Citations by year
2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 1
FWCI
0.45
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Manitoba
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Family and Disability Support Research
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
autism spectrum disorder, children with autism, caregiver perspectives, parents, pharmacists, medication effectiveness, risperidone, methylphenidate, aripiprazole, melatonin, occupational therapy, ADHD comorbidity, aggression, health care access, access to education
MeSH terms
Autism Spectrum Disorder, Adolescent, Central Nervous System Depressants, Child, Female, Humans, Male, Melatonin, Caregivers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review